SCHEMBL17599324

SCHEMBL17599324

COC(=O)c1cc(-c2ccc(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)c3ccccc23)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ CRHBP P24387 1/20 0.47
▸ CRHR2 Q13324 1/20 0.47
▸ KEAP1 Q14145 4/20 0.44
▸ NFE2L2 Q16236 2/20 0.44
▸ MCL1 Q07820 3/20 0.44
▸ GAA P10253 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ TP53 P04637 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ FABP4 P15090 5/20 0.40
▸ FABP5 Q01469 3/20 0.40
▸ ACLY P53396 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599358 0.90 ALDH1A1 (0.58) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599470 0.84 MEN1 (0.46) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17613349 0.80 SLC6A4 (0.36) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599370 0.76 ALDH1A1 (0.53) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599346 0.76 CDC25B (0.45) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599329 0.76 KMT2A (0.55) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599499 0.76 KEAP1 (0.48) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599380 0.75 MEN1 (0.44) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599372 0.74 ALDH1A1 (0.62) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599423 0.74 ALDH1A1 (0.56) MEN1KMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback